AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow +18.9% ·
net new positions -9.1%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | n/a | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | n/a | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | n/a | n/a |
| Q2 2024 | 11 | n/a | 2.57M | $51.15M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.93M | -1.6% | $27.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 1.09M | +120.2% | $15.61M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 1.08M | +3.4% | $15.43M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 547.74K | +508.4% | $7.85M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 192.86K | +46.4% | $2.70M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 6 | Citadel Advisors ✦ | 132.19K | +295.6% | $1.89M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Arrowstreet Capital ✦ | 51.21K | -80.3% | $733,811 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 47.45K | +5.7% | $680,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 39.34K | -39.3% | $563,758 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Gotham Asset Management ✦ | 22.16K | -21.5% | $317,567 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 16.90K | New | $242,177 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $242,177 | 0.0% |
Exited
| Norges Bank | $1.66M | was 0.0% |
| Two Sigma Investments | $1.16M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 44.71M shares, $512.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.